Targeting the tumor vasculature with combretastatin A-4 disodium phosphate: effects on radiation therapy
- 1 November 1998
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 42 (4) , 899-903
- https://doi.org/10.1016/s0360-3016(98)00320-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Angiogenesis in the Pathobiology and Treatment of Vascular and Malignant DiseasesThe Annals of Thoracic Surgery, 1997
- Angiogenesis as a Target for Tumor TreatmentOncology, 1997
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Anti—vascular approaches to solid tumour therapy: Evaluation of vinblastine and flavone acetic acidInternational Journal of Cancer, 1995
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- Podophyllotoxin, steganacin and combretastatin: Natural products that bind at the colchicine site of tubulinPharmacology & Therapeutics, 1993
- Angiogenesis.Journal of Biological Chemistry, 1992
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989
- Antineoplastic Agents, 122. Constituents of Combretum caffrumJournal of Natural Products, 1987
- Endothelial proliferation in tumours and normal tissues: Continuous labelling studiesBritish Journal of Cancer, 1984